References
- Stamm WE, Jones RB, Batteiger BE. Chlamydia tra-chomatis. In: Mandell GL, Bennett JE, Dolin R, ed. Principles and practice of infectious diseases. 6th ed. London: Churchill Liv-ingstone; 2005: 2240–54.
- Pechere JC, ed. Intracellular bacterial infections. Cam-bridge: Medical Publications; 1996: 59–64.
- Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infec-tion in sexual partnerships. JAMA 1996; 276: 1737–42.
- Gomberg M. Persistent Chlamydial Infection. Medicus 2003; 12: 179–88.
- Epidemiology Service. Croatian National Institute of Public Health. http://,www.hzjz.hr/
- Ŝkerk V, Čajić V, Markovinović L, et al. Etiology of chronic prostatitis syndrome in patients treated at the University Hospi-tal for Infectious Diseases “Dr. Fran Mihaljevié” from 2003 to 2005. Coll Antropol 2006; 30 (Suppl 2):145-9.
- Ŝkerk V, Krhen I, Schönwald S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24 (Suppl 1):553–6.
- Hir§l-Heéej V, Pustgek N, Sikanio-Dugié N, Domljan LM, Kani D. Prevalence of chlamydial genital infection and associated risk factors in adolescent females at an urban reproductive health care center in Croatia. Coll Antropol 2006; 30 (Suppl.2):131-7.
- Hir3l-Heéej V, Sikanié-Dugié N, Domljan LM, Pustgek N, Kani D, Zele-Staxtevié L. Chlamydia trachomatis in adolescents and young women. 9th Symposium on sexually transmitted dis-eases and urogenital infections. Opatija, March 17-19, 2007. Abstract book, p.40-1.1°
- Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guide-lines, 2006. MMWR Recomm Rep 2006; 55( RR-11):1-94.
- Skerk V, Krhen I, Francetie I, Bartle B, Vreie H. New view on treatment of sexually transmitted diseases with azithromycin. Medicus 2004; 13: 247–53.
- Skerk V. Treatment of sexually transmitted infections. PLIVA udli§te Glasnik 2008;(26):1-4.
- Skerk V, Schönwald S, Krhen I, et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia tra-chomatis. J Chemother 2001; 13: 664–5.
- Skerk V, Krhen I, Lisle M, et al. Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis-a randomized study. J Chemother 2004; 16: 408-10.
- Magri V, Trinchieri A, Ceriani I, Marras E, Perletti G. Erad-ication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. Arch Ital Urol Androl 2007; 79: 93–8.
- Magri V, Trinchieri A, Pozzi G, et al. Efficacy of repeated cycles of combination therapy for the eradication of infecting or-ganisms in chronic bacterial prostatitis. Int J Antimicrob Agents 2007; 29: 549–56.